TCM
BSX icon

Tandem Capital Management’s Boston Scientific BSX Stock Holding History

Tandem Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.21M Sell
51,170
-1,520
-3% -$122K 1.61% 16
2025
Q4 		$5.02M Sell
52,690
-70
-0.1% -$6.86K 2.29% 11
2025
Q3 		$5.15M Sell
52,760
-284
-0.5% -$29.4K 2.4% 10
2025
Q2 		$5.7M Sell
53,044
-660
-1% -$66.8K 2.88% 7
2025
Q1 		$5.42M Sell
53,704
-842
-2% -$84.8K 3.03% 7
2024
Q4 		$4.87M Sell
54,546
-605
-1% -$53.3K 2.61% 8
2024
Q3 		$4.62M Sell
55,151
-2,715
-5% -$214K 2.43% 8
2024
Q2 		$4.42M Sell
57,866
-485
-0.8% -$35.5K 2.42% 10
2024
Q1 		$4M Sell
58,351
-125
-0.2% -$8.04K 2.27% 11
2023
Q4 		$3.38M Sell
58,476
-1,400
-2% -$74.7K 2.1% 12
2023
Q3 		$3.16M Sell
59,876
-450
-0.7% -$23.6K 2.17% 10
2023
Q2 		$3.26M Sell
60,326
-600
-1% -$31.3K 2.13% 12
2023
Q1 		$3.05M Sell
60,926
-478
-0.8% -$22.5K 2.15% 12
2022
Q4 		$2.84M Sell
61,404
-760
-1% -$32.9K 2.24% 12
2022
Q3 		$2.52M Sell
62,164
-90
-0.1% -$3.61K 2.13% 12
2022
Q2 		$2.32M Hold
62,254
– – 1.86% 17
2022
Q1 		$2.73M Sell
62,254
-520
-0.8% -$22.5K 1.89% 17
2021
Q4 		$2.67M Buy
62,774
+1,125
+2% +$47.3K 1.54% 24
2021
Q3 		$2.67M Buy
61,649
+280
+0.5% +$12.4K 1.68% 20
2021
Q2 		$2.62M Sell
61,369
-270
-0.4% -$11.4K 1.65% 21
2021
Q1 		$2.38M Sell
61,639
-550
-0.9% -$20.8K 1.65% 25
2020
Q4 		$2.24M Buy
62,189
+650
+1% +$23.4K 1.68% 23
2020
Q3 		$2.35M Sell
61,539
-300
-0.5% -$11.6K 2.08% 17
2020
Q2 		$2.17M Sell
61,839
-6,260
-9% -$225K 2.13% 16
2020
Q1 		$2.22M Buy
68,099
+2,020
+3% +$78.9K 2.5% 11
2019
Q4 		$2.99M Buy
+66,079
New +$2.76M 2.56% 7

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Tandem Capital Management's BSX Position: Q1 2026 in Review

Tandem Capital Management reduced its Boston Scientific (BSX) stake by 2.9% in Q1 2026, selling an estimated $122K and leaving 51,170 shares worth $3.21M. The position accounts for 1.61% of the portfolio, ranked #16.

Tandem Capital Management first reported a position in BSX in Q4 2019 and has held it in 26 quarters since. The position peaked at $5.7M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Tandem Capital Management held 51,170 shares of Boston Scientific worth $3.21M as of Q1 2026.
  • Tandem Capital Management sold 1,520 Boston Scientific shares in Q1 2026, an estimated $122K.
  • Boston Scientific made up 1.61% of Tandem Capital Management's portfolio in Q1 2026, its #16 holding.
  • Tandem Capital Management first reported a position in Boston Scientific in Q4 2019 and has held it in 26 quarters since.
  • Tandem Capital Management's Boston Scientific position peaked at $5.7M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Tandem Capital Management's 13F filing for Q1 2026, filed 16 Apr 2026.